Implants, stents and lenses: the prices that are capped by law, and how to check yours

Why implants are where surgical bills go wrong

An implant is the one item on a surgical bill that a patient cannot evaluate, cannot compare, and usually cannot even see. It arrives described only as a brand name, it is chosen by somebody else, and its price historically bore very little relation to what it cost to make or import. That combination is why India ended up regulating it directly rather than leaving it to the market.

The regulation exists because the margins found were extraordinary. Investigations by the National Pharmaceutical Pricing Authority into cardiac stents and knee implants documented mark-ups through the distribution chain that in some cases multiplied the landed cost several times over before the patient was billed. That is what led to ceiling prices for those two categories and later to capped trade margins for a wider set of notified devices.

The practical effect is that for stents and knee implants you are no longer negotiating. There is a legally fixed maximum, it is published, it applies to every brand including imported ones, and a bill above it is not expensive, it is unlawful. Very few patients know this, and that is the only reason overcharging still occurs.

For everything else, including meshes, spinal hardware, intraocular lenses, orthopaedic plates and screws, the position is looser. Some devices are notified for trade margin capping, others are not, and prices vary enormously with no ceiling to check against. There the protection is different: it comes from documentation, from asking what the cheaper option is and why it is not being used, and from a second opinion when a premium device is being pressed on you.

The numbers, as they currently stand

Cardiac stents are capped. As revised with effect from April 2025, the ceiling price is Rs 10,692.69 for a bare metal stent and Rs 38,933.14 for a drug-eluting stent or a bioresorbable vascular scaffold, in each case exclusive of applicable tax. These figures are revised periodically, usually annually in line with the wholesale price index, so check the current notification for the year in which your procedure takes place. The principle does not change even when the figures do.

Knee implants are capped. Ceiling prices were fixed for the femoral, tibial, patellar and insert components of a total knee replacement, with separate categories for cobalt chromium, titanium and oxidised zirconium systems, and for revision and special implants. A total knee system in the standard category falls well below the sums that were commonly billed before regulation. Ask for the component-wise breakup, because a knee implant is billed as a set of parts and the ceilings are set part by part.

For other notified devices, the trade margin rationalisation approach applies instead of a fixed ceiling. The price at first point of sale, meaning the price at which the importer or manufacturer sells, may be marked up by no more than 12% by the distributor and a further 4% by the hospital. That structure is what makes the implant invoice so important: the invoice reveals the first point of sale price against which the margin can be measured.

Two clarifications that hospitals sometimes blur. The cap is inclusive of everything except applicable tax, so separate handling, storage, import or breakage charges added on top of a capped price are not permissible. And the cap does not vary by room category, hospital tier or package level, so an implant cannot legitimately cost more because you are in a private room.

If a hospital tells you the capped implant is unavailable and only a costlier alternative can be used, ask for that in writing, with the reason. In a genuine emergency, proceed with treatment and pursue the paperwork afterwards. In a planned operation, unavailability of the regulated option is something you can wait a few days for.

The three documents that protect you

First, the implant invoice. This is the purchase invoice showing what the hospital paid and to whom. It is the document that makes trade margin capping enforceable, and it is the one most often withheld. Ask for it, and ask before the operation so that the request is not retrospective.

Second, the sticker or label with the batch or lot number, the model, the manufacturer and the maximum retail price. Every implant comes in packaging that carries this, and standard practice is for one copy to be pasted into your case file and one made available to you. Photograph it. This is what identifies exactly which device is inside your body.

Third, the printed maximum retail price on the packaging, which for capped categories must not exceed the notified ceiling. Comparing the printed price against the notified ceiling is a thirty-second check that most patients never perform.

Add to those the implant card where one is issued, particularly for joint replacements and cardiac devices, and keep everything permanently. This matters beyond billing. Before any future MRI scan, any future revision surgery, or any dental or surgical procedure needing antibiotic cover, somebody will need to know precisely what is implanted in you. Patients who cannot say what device they have are put through avoidable investigation to find out.

One more request worth making at the same time: ask for the implant details to be written into your discharge summary, not only into the bill. Bills get lost and discharge summaries get kept.

The upsell conversation, and how to handle it

The premium device conversation follows a recognisable script across specialties. There is a standard option, described briefly and slightly apologetically, and a premium option described with enthusiasm, usually imported, usually said to last longer, and priced substantially higher. You are asked to choose, often on the day, often with your family present, and the framing makes the cheaper option feel like a compromise on your own health.

The honest position is that premium options are sometimes genuinely better for specific patients and sometimes not better for anybody. Intraocular lenses are the clearest example. A multifocal or extended-depth lens can reduce spectacle dependence, which some people value highly, and it can also produce glare and halos that a monofocal lens would not. A monofocal lens is not an inferior lens; it is a different trade-off. Whether the premium is worth it depends on your eyes, your work and your tolerance for visual side effects, not on how the two were described to you.

In joint replacement, the evidence for longer survival of premium bearing surfaces in older patients with modest activity levels is much weaker than the sales conversation suggests. For a younger, more active patient it can matter more. That is a real clinical discussion, and the way to open it is to ask what evidence supports the difference for someone with your age and activity level, specifically.

Five questions cut through the whole thing. What is the difference in outcome for a patient like me, and what evidence supports it? What are the disadvantages of the premium option, because everything has some? What would you use for your own parent? Is the standard option under a price cap while the premium one is not? And will my insurance cover the difference, or am I paying it myself?

That fourth question deserves emphasis because it explains a great deal of behaviour. Where a capped category exists, there is a financial incentive to steer patients towards uncapped premium alternatives, and asking the question out loud changes the conversation immediately.

Decide before the day of surgery, in writing, on the consent form. A choice made while gowned and waiting is not a choice.

Where to complain, and what actually works

Start at the billing desk, in writing, on the day, with the notified ceiling price quoted and the excess identified. Get a dated acknowledgment and the name and designation of the person handling it. Many overcharges are reversed at this stage, which is precisely why the written request matters.

If that fails, escalate within the hospital to the medical superintendent or the grievance officer, again in writing. Attach the bill, the implant sticker, the invoice if you have it, and the ceiling price notification.

Then go outside the hospital, and go to the price regulator rather than only to a consumer body. Overcharging above a notified ceiling price or beyond a capped trade margin is a matter for the National Pharmaceutical Pricing Authority, which has acted on documented complaints and has recovered overcharged amounts with interest. There is also a national consumer helpline that routes such complaints. What makes these complaints succeed is documents, specifically the bill and the implant sticker together.

In parallel, if you are insured, tell your insurer. Insurers have their own interest in overcharged implants and their own leverage with hospitals, and an insurer disputing a line item is often more effective than a patient doing so alone.

The consumer forum remains available for deficiency of service, and healthcare falls within consumer protection law. It is slower, and it works on the same documents. For a scheme beneficiary charged for an implant that a covered package should have included, the scheme's own grievance mechanism is the fastest route, because empanelment is at stake.

One practical note that decides many of these cases. If you must pay to secure discharge, write 'paid under protest, amount disputed' on your copy of the receipt before signing anything. Paying under protest preserves the claim. Paying in silence largely surrenders it.

The clinical side, which matters more than the price

It would be a poor page that made you an expert on implant pricing and left you unable to ask whether you need the implant at all. That question comes first, and this site has separate pages on it for knee replacement, spine surgery, cardiac stents and hernia mesh. A correctly priced implant you did not need is a worse outcome than an overpriced implant you did.

For stents specifically, the distinction that matters is between a heart attack, where opening the artery promptly saves heart muscle and life, and stable chest pain, where medication and structured exercise perform comparably to stenting for survival in a large body of trial evidence. Those two situations look similar on an angiogram and could not be more different in what they justify. The angiogram itself is often performed and the stent decided in the same sitting, which is exactly the circumstance in which nobody has time to think.

For knee replacement, the question is whether the non-surgical ladder has actually been climbed: weight, supervised strengthening physiotherapy rather than a printed sheet, and a proper trial of medication. A knee that has never had eight to twelve weeks of supervised exercise has not had its alternatives tried.

For hernia mesh, the mesh itself is generally the right answer for most adult hernias, and the questions are about the technique and about who is doing it more than about the device.

Once you have decided the implant is warranted, ask the questions that concern the device as a device rather than as a price: how many of these has this unit implanted, is the model widely used and supported in India, and if it needs revising in ten years will the components still be available? An implant from a range that has been withdrawn is a genuine long-term problem, and it is a question almost nobody asks.

And keep the paperwork. Twenty years from now, in front of a different doctor in a different city, the photograph of your implant sticker will be the most useful thing in your file.